Thursday 19 September 2019 ,
Thursday 19 September 2019 ,
Latest News
  • Nursing education to be upgraded: PM
  • Open your eyes: UN envoy to Suu Kyi
  • Trump to meet Imran, Modi for talks focusing on Kashmir
  • Bangladesh to seek expeditious global efforts to resolve Rohingya crisis
  • Dhaka ranks 7th worst in Air Quality Index
  • 536 new dengue patients hospitalised in 24 hrs: DGHS
9 September, 2019 00:00 00 AM

FAK protein linked to chemotherapy resistance in ovarian cancer

MedicalXpress
FAK protein linked to chemotherapy resistance in ovarian cancer
Staining of a tumor biopsy isolated from a patient with ovarian cancer shows elevated levels of activated FAK (brown) within a tumor implant compared to surrounding normal tissue. Credit: UC San Diego Health Sciences

Although the number of women being diagnosed and dying of ovarian cancer is declining, recurrence, drug resistance and mortality remain high for women with high-grade serous ovarian carcinoma, the most common form of epithelial ovarian cancer. A new study in the journal eLife by University of California San Diego School of Medicine researchers links changes in the gene for the protein focal adhesion kinase, or FAK, to the cancer's ability to survive chemotherapy.

"We have linked elevated levels of FAK, or gene amplification, to the survival of cancer stem cells in a new tumor model," said David D. Schlaepfer, Ph.D., professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at UC San Diego School of Medicine, UC San Diego Moores Cancer Center researcher and co-principal investigator.

"This was not expected. We knew FAK helped tumors to spread, but we were surprised to find that FAK supports DNA repair in the most important stem-like cells of the tumor.

This may be an important tool that tumors use to resist platinum chemotherapy, which is the current standard of care."

In the majority of patients, ovarian tumors exhibit high levels of FAK, said Dwayne G. Stupack, Ph.D., associate professor in the Division of Gynecologic Oncology at Moores Cancer Center and co-principal investigator.

"There are drugs being tested in early phase clinical trials, including at UC San Diego Health, that inhibit FAK," said Stupack. "When we treated mice that had chemo-resistant tumors with a FAK inhibitor they responded to chemotherapy. Mice that did not receive the FAK inhibitor were resistant. By understanding the biology behind this, it can help us prepare better combinations of drugs for the clinic."

The ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK, led by Michael McHale, MD, professor in the UC San Diego School of Medicine Department of Obstetrics, Gynecology and Reproductive Sciences and chief of the Division of Gynecologic Oncology Services at UC San Diego Health, is investigating the combination of the investigational FAK inhibitor defactinib with the chemotherapy drugs carboplatin and paclitaxel for patients with chemo-resistant ovarian cancer.

"If we can prevent recurrence, we may be able to provide great benefit to patients," said McHale, a co-author on the study.

The National Cancer Institute (NCI) estimates that 22,350 women will be diagnosed with ovarian cancer in 2019 and 13,980 will die. Approximately 1 in 70 women will be diagnosed with this disease in their lifetime. Breast cancer affects nine times more women than ovarian cancer, but according to the NCI, almost nine out of 10 women will survive five years or longer with breast cancer. More than half of women with ovarian cancer will die within five years of diagnosis.

Cure or remission is dependent on the elimination of all cancer cells, including microscopic disease. Ovarian cancer cells often spread to other parts of a woman's body before an official diagnosis. The cells can grow as tiny clumps or as larger balls, called tumorspheres. In the majority of patients, ovarian cancer cells develop chemotherapy resistance.

The collaborative study, led by Schlaepfer and Stupack, focused on high-grade serous ovarian carcinoma, a subtype of epithelial cancer that starts in the outer surface of the ovaries or fallopian tubes. It makes up approximately 52 percent of malignant ovarian cancer and accounts for the highest number of deaths.

Researchers compared ovarian cancer cells in mouse models at early and late stages of the disease. The late-stage, aggressive cells exhibited greater genetic changes, and could grow as tumorspheres in lab dishes. One of these changes affected the gene for FAK, which was found to have more copies than normal.

The FAK protein is an enzyme that helps cancer cells move around. In cells from mice with late-stage cancer, FAK was over-active and present at high levels. When grown as tumorspheres, the FAK-overactive tumors were more resistant to chemotherapy than their early-stage counterparts. Among patients who had received chemotherapy, the team found that surviving tumor cells also displayed high levels of FAK activity.

To understand how FAK makes ovarian cancer cells resistant to chemotherapy, the researchers used gene-editing to delete the FAK gene. They found that, without FAK, cells became deficient in a group of detoxifying enzymes as well as others that repair damaged DNA.

"Patients with ovarian cancer generally respond well to first-line therapy, but in most cases, the cancer returns," said Schlaepfer.

"We know that a subpopulation of stem-like cancer cells can survive chemotherapy and lead to recurrence, drug resistance and even death," said Schlaepfer. "These findings suggest FAK is an important and potential therapeutic vulnerability underlying tumor recurrence."

Courtesy: University of California - San Diego

 

Comments

Most Viewed
Digital Edition
More story
Editor Speaks

Editor Speaks

Communication between organs to organs is vital and this is done by a chemical messenger comprising feedback loops of hormones released by internal organs…
How to keep your legs healthy?

How to keep your legs healthy?

In this fast changing world, you will be hearing quite often your family members especially in their fifties complaining now and then about all kinds…
What are hormones?

What are hormones?

A hormone is a chemical released by one or more cells that affects cells in other parts of the organism. Only a small amount of hormone is required to…
What to know about hormonal imbalances

What to know about hormonal imbalances

Hormonal imbalances occur when there is too much or too little of a hormone in the bloodstream. Because of their essential role in the body, even small…
Adrenal fatigue is the root of many illnesses

Adrenal fatigue is the root of many illnesses

ALEX HOWARD The adrenal glands sit on top of the kidneys and produce a number of hormones such as adrenalin, noradrenalin, cortisol and DHEA. These hormones…
Andropause

Andropause

Andropause, also sometimes called male menopause, is an acquired type of hypogonadism caused by the gradual decline of testosterone levels as a result…
Can gut bacteria affect how we store fat?

Can gut bacteria affect how we store fat?

DARLA LEAL Gut bacteria or microbes live in our digestive tract helping us digest food, prevent infection, and shown to play a role in our physical fitness.…
How old is too old to go to the pediatrician?

How old is too old to go to the pediatrician?

For most parents, getting started with a pediatrician is the easy part. Chances are that even before you gave birth, you had researched doctors certified…
Britain slumps to bottom of cancer survival league tables – and is two decades behind some countries

Britain slumps to bottom of cancer survival league tables – and is two decades behind some countries

 LAURA DONNELLY   Britain is bottom of international league tables for cancer survival – and is lagging two decades behind some countries…
Hypertension: The No. 1 sign you have high blood pressure

Hypertension: The No. 1 sign you have high blood pressure

KORIN MILLER  Hypertension is known as the “silent killer” and it’s not something that you want to mess with. One in three Americans…
Prof. Dr. Afzal performed the first  zero-contrast angioplasty  in Bangladesh

Prof. Dr. Afzal performed the first zero-contrast angioplasty in Bangladesh

Zero-contrast angioplasty was done, for the first time in Bangladesh, on 30 July 2019 in the National Institute of Cardiovascular Diseases (NICVD). Prof.…
Heavy menstrual bleeding: Keyhole hysterectomy technique 'more effective'

Heavy menstrual bleeding: Keyhole hysterectomy technique 'more effective'

A keyhole-surgery technique for treating heavy menstrual bleeding is more effective and just as safe as a non-invasive alternative, a study of more than…
Full chemo doses may improve survival in breast cancer

Full chemo doses may improve survival in breast cancer

Maintaining full doses of chemotherapy, especially early in the treatment course, is important for survival of intermediate or high-risk breast cancer…
Anti-addiction meds can help teen Opioid abusers

Anti-addiction meds can help teen Opioid abusers

The epidemic of opioid addiction and abuse ravaging the United States is also affecting teenagers. Now, research confirms that anti-addiction medications…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting